The better way to run single cell genomics
Company was acquired
Event Year: 2020
Company was acquired
Event Year: 2020
Dropprint Genomics developed specialized software designed to analyze the activity of individual cells, offering a more precise approach compared to traditional methods that examine aggregate cell behavior. This innovative technique allows for the identification of specific cellular activities, analogous to pinpointing a speeding car in traffic by monitoring each vehicle individually. The company addressed key barriers to entry in the single-cell genomics market, namely cost and data analysis complexity. By reducing costs tenfold and establishing a scalable computational infrastructure, Dropprint Genomics facilitated broader adoption of this technology. Leveraging expertise from a leading single-cell genomics lab, the team pioneered the processing and analysis of millions of immune cells, applying big data solutions to immunological research. The company built a database of over one million immune cells from diverse states (healthy, cancerous, autoimmune) through paid partnerships. This growing database, combined with machine learning software, enabled a data-centric approach to improve target discovery, with the models continually learning to provide more precise, unbiased, and automated single-cell genomics insights.
Dropprint Genomics developed specialized software designed to analyze the activity of individual cells, offering a more precise approach compared to traditional methods that examine aggregate cell behavior. This innovative technique allows for the identification of specific cellular activities, analogous to pinpointing a speeding car in traffic by monitoring each vehicle individually. The company addressed key barriers to entry in the single-cell genomics market, namely cost and data analysis complexity. By reducing costs tenfold and establishing a scalable computational infrastructure, Dropprint Genomics facilitated broader adoption of this technology. Leveraging expertise from a leading single-cell genomics lab, the team pioneered the processing and analysis of millions of immune cells, applying big data solutions to immunological research. The company built a database of over one million immune cells from diverse states (healthy, cancerous, autoimmune) through paid partnerships. This growing database, combined with machine learning software, enabled a data-centric approach to improve target discovery, with the models continually learning to provide more precise, unbiased, and automated single-cell genomics insights.
Total Raised: Unknown (Y Combinator backed)
Last Round: Winter 2020
Total Raised: Unknown (Y Combinator backed)
Last Round: Winter 2020
Healthcare
Healthcare
Healthcare -> Drug Discovery and Delivery
Healthcare -> Drug Discovery and Delivery
Team size: 2
Hiring: No
Team size: 2
Hiring: No